User profiles for A. Ammendola

Alessandra Amendola

Dirigente biologo, Laboratorio di Virologia, INMI "L. Spallanzani", Roma
Verified email at inmi.it
Cited by 3769

Rising behind NO: cGMP-dependent protein kinases

F Hofmann, A Ammendola… - Journal of cell …, 2000 - journals.biologists.com
Over the past few years, a wealth of biochemical and functional data has been gathered on
mammalian cGMP-dependent protein kinases (cGKs). In mammals, three different kinases …

Results of high tibial osteotomy: review of the literature

A Amendola, DE Bonasia - International orthopaedics, 2010 - Springer
The aim of this review is to evaluate long-term follow-up and survival analysis studies regarding
high tibial osteotomies (HTO) for the treatment of medial knee arthritis. Despite the good …

Syndesmotic ankle sprains in athletes

…, MH Jones, A Amendola - The American journal of …, 2007 - journals.sagepub.com
Ankle sprains are among the most common athletic injuries and represent a significant source
of persistent pain and disability. Despite the high incidence of ankle sprains in athletes, …

Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ

J Schlossmann, A Ammendola, K Ashman, X Zong… - Nature, 2000 - nature.com
Calcium release from the endoplasmic reticulum controls a number of cellular processes,
including proliferation and contraction of smooth muscle and other cells 1 , 2 . Calcium release …

[HTML][HTML] Molecular Determinants of the Interaction between the Inositol 1, 4, 5-Trisphosphate Receptor-associated cGMP Kinase Substrate (IRAG) and cGMP Kinase Iβ …

A Ammendola, A Geiselhöringer, F Hofmann… - Journal of Biological …, 2001 - ASBMB
Cyclic GMP-dependent protein kinase I (cGKI) affects the inositol 1,4,5-trisphosphate (InsP
3 )-dependent release of intracellular calcium by phosphorylation of IRAG (inositol 1,4,5-…

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma–the SHELTER study

…, NP Malek, J Holzapfel, T Herz, AS Ammendola… - Journal of …, 2016 - Elsevier
Background & Aims No established therapies for patients with hepatocellular carcinoma (HCC)
and progression on first-line sorafenib treatment currently exist. This phase I/II trial …

[HTML][HTML] 2019-novel coronavirus severe adult respiratory distress syndrome in two cases in Italy: an uncommon radiological presentation

…, C Agrati, G Amadei, A Amendola… - International Journal of …, 2020 - Elsevier
Introduction Several recent case reports have described common early chest imaging findings
of lung pathology caused by 2019 novel Coronavirus (SARS-COV2) which appear to be …

The effect of bracing on varus gonarthrosis

A Kirkley, S Webster-Bogaert, R Litchfield, A Amendola… - JBJS, 1999 - journals.lww.com
Background: The purpose of this study was to compare a custom-made valgus-producing
functional knee (unloader) brace, a neoprene sleeve, and medical treatment only (control …

Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study

…, A Sturm, R Voiosu, A Ammendola… - Journal of Crohn's …, 2013 - academic.oup.com
Background: Vidofludimus (SC12267) is a novel oral immunomodulator inhibiting dihydroorotate
dehydrogenase (DHODH) and the expression of proinflammatory cytokines including …

[HTML][HTML] Epidemiology of ankle arthritis: report of a consecutive series of 639 patients from a tertiary orthopaedic center

…, A Hayes, JA Buckwalter, A Amendola - The Iowa orthopaedic …, 2005 - ncbi.nlm.nih.gov
The purpose of our study was to identify the cause of symptomatic ankle arthritis in a
consecutive series of patients presenting in a tertiary care setting. Between 1991 and 2004, 639 …